BioRestorative Therapies, Inc.
BRTX
$1.71
$0.021.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.64M | -1.09M | -4.03M | -2.22M | -2.30M |
| Total Depreciation and Amortization | 50.40K | 48.30K | 47.70K | 42.70K | 42.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -850.70K | -879.20K | 1.92M | 338.50K | 544.30K |
| Change in Net Operating Assets | 88.60K | 222.80K | 193.00K | -475.70K | 129.10K |
| Cash from Operations | -2.35M | -1.70M | -1.87M | -2.32M | -1.59M |
| Capital Expenditure | -12.40K | -58.50K | -35.30K | -- | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.55M | 995.20K | 3.01M | -4.93M | -14.80K |
| Cash from Investing | 1.53M | 936.80K | 2.97M | -4.93M | -84.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 595.40K | 0.00 | 7.53M | 83.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -126.30K | -595.40K | -12.80K | -9.50K | -- |
| Cash from Financing | -126.30K | 0.00 | -12.80K | 7.52M | 83.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -941.60K | -762.80K | 1.10M | 272.70K | -1.59M |